Chronic Chlamydia pneumoniae infection may promote coronary artery disease in humans through enhancing secretion of interleukin-4

Clinical and Experimental Immunology

Volumn 146, Issue 2, 2006, Pages 197-202

  Clancy, R ^a,b   Ren, Z ^b   Pang, G ^b   Fletcher, P ^b   D'Este, C ^c  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Helicobacter pylori; IFN ; IL 4

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CD4 LYMPHOCYTE COUNT; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; THORAX PAIN;

AGED; C-REACTIVE PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 33750051335     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03185.x     Document Type: Article

References (39)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-26.
2. Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 8618:983-6.
3. Gupta S, Camm AJ. Chronic infection in the etiology of atherosclerosis - the case for Chlamydia pneumoniae. Clin Cardiol 1997; 20:829-36.
4. Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis - what we know and what we don't. Clin Microbiol Infect 2002; 8:2-13.
5. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-43.
6. Schumacher A, Lerkerod AB, Seljeflot I et al. Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol 2001; 39:1859-64.
7. Goodwin CS, Blincow E, Peterson G et al. Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. J Infect Dis 1987; 155:488-94.
8. Ren Z, Pang G, Lee R et al. Circulating T-cell response to Helicobacter pylori infection in chronic gastritis. Helicobacter 2000; 5:135-41.
9. Surcel HM, Syrjala H, Leinonen M, Saikku P, Herva E. Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro. Infect Immun 1993; 61:2196-9.
10. Langer F, Ingersoll SB, Amirkhosravi A et al. The role of CD40 in CD40L- and antibody-mediated platelet activation. Thromb Haemost 2005; 93:1137-46.
11. Inwald DP, McDowall A, Peters MJ, Callard RE, Kelin NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003; 92:1041-6.
12. Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK. Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000; 102:1114-19.
13. Szabolcs MJ, Cannon PJ, Thienel U et al. Analysis of CD154 and CD40 expression in native coronary atherosclerosis and transplant associated coronary artery disease. Virchows Arch 2000; 437:149-59.
14. Wang CL, Wu YT, Liu CA et al. Expression of CD40 ligand on CD4+ T cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 2003; 111:E140-7.
15. Leiva LE, Butler B, Hempe J, Ortigas AP, Sorensen RU. Up-regulation of CD40 ligand and induction of a Th2 response in children immunised with pneumococcal polysaccharide vaccines. Clin Diagn Lab Immunol 2001; 8:233-40.
16. Jeurissen A, Wuyts G, Kasran A et al. The human antibody response to pneumococcal capsular polysaccharides is dependent on the CD40-CD40L interaction. Eur J Immunol 2004; 34:850-8.
17. Almeida GM, Andrade RM, Bento CA. The capsular polysaccharides of Cryptococcus neoformans activate normal CD4+ T cells in a dominant Th2 pattern. J Immunol 2001; 167:5845-51.
18. Radke PW, Merkelbach-Bruse S, Messmer BJ et al. Infectious agents in coronary lesions obtained by endatherectomy: pattern of distribution, coinfection, and clinical findings. Coron Artery Dis 2001; 12:1-6.
19. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol 2002; 22:1547-59.
20. Mosorin M, Surcel HM, Laurila A et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol 2000; 20:1061-7.
21. Curry AJ, Portig I, Goodall JC, Kirkpatrick PJ, Gaston JS. T lymphocyte lines isolated from atherosclerotic plaque contain cells capable of responding to Chlamydia antigens. Clin Exp Immunol 2000; 121:261-9.
22. Ford P, Gemmell E, Walker P, West M, Cullinan M, Seymour G. Characterisation of heat shock protein-specific T cells in atherosclerosis. Clin Diagn Lab Immunol 2005; 12:259-67.
23. Benagiano M, Azzurri A, Ciervo A et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci USA 2003; 100:6658-63.
24. Bobryshev YV, Cao W, Phoon MC et al. Detection of Chlamydophila pneumoniae in dendritic cells in atherosclerotic lesions. Atherosclerosis 2004; 173:185-95.
25. George J, Mulkins M, Shaiash A et al. Interleukin-4 deficiency does not influence fatty streak formation in C57Bl/6 mice. Atherosclerosis 2000; 153:403-11.
26. King VL, Szilvassy SJ, Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in site-specific manner in female LDL receptor -/- mice. Arterioscler Thromb Vasc Biol 2002; 22:456-61.
27. Shimizu K, Schonbeck U, Mach F, Libby P, Mitchell RN. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol 2000; 165:3506-18.
28. Khew-Goodall Y, Wadham C, Stein BN, Gamble JR, Vadas MA. Stat6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells. Artheroscler Thromb Vass Biol 1999; 19:1421-9.
29. Kotowicz K, Dixon GL, Klein NJ, Peters MJ, Callard RE. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology 2000; 100:441-8.
30. Lee YW, Kuhn H, Kaiser S, Hennig B, Daugherty A, Toborek M. Interleukin-4 induces transcription of the 15-lipoxgenase 1 gene in human endothelial cells. J Lipid Res 2001; 42:783-91.
31. Barks JL, McQuillin JJ, Iademarco MF. TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J Immunol 1997; 159:4532-8.
32. Sasaguri T, Arima N, Tanimoto A, Shimajiri S, Hamada T, Sasaguri Y. A role for interleukin-4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells. Atherosclerosis 1998; 138:247-53.
33. Cornicelli JA, Butteiger D, Rateri DL, Welch K, Daugherty A. Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages. J Lipid Res 2000; 41:376-83.
34. Loomis WP, Starnbach MN. T cell responses to Chlamydia trachomatis. Curr Opin Microbiol 2002; 5:87-91.
35. Espinola-Klein C, Rupprecht HJ, Blankenberg S et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002; 105:15-21.
36. Sotiropoulos A, Gikas A, Skourtis S et al. Serpositivity to Chlamydia pneumoniae or Helicobacter pylori and coronary artery disease. Int J Cardiol 2006; 109:420-1.
37. Danesh J. Antibiotics in the prevention of heart attacks. Lancet 2005; 365:365-7.
38. Cannon CP, Braunwald E, McCabe CH et al. Provastatin or atorvastatin evaluation and infection therapy (TIMI 22) antibiotic trial. European Society of Cardiology Congress, August 28-September 1, 2004: Munich, Germany.
39. Kaski JC. ACES and PROVE-IT: a death sentence for the infectious hypothesis of atherosclerosis? Eur Cardiol J 2005; 10.